$MELI
Price history, market instrument context, member research, and related headlines in one place.
MELI key statistics
NasdaqGSUSD
52-week range
$1,495.0039%$2,428.00
Latest session $1,811.05–$1,876.00MercadoLibre, Inc. (MELI) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $1,856.98, up $17.87 (0.97%) from the previous close of $1,839.11. It has traded between $1,811.05 and $1,876.00 in the latest session. Over the past year it has ranged from $1,495.00 to $2,428.00, leaving it in the lower half of its 52-week range (39%). Reported volume for the session was 467.6K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Here’s Why MercadoLibre (MELI) Offers Long Runway for Growth? — See source for full details.
MercadoLibre (MELI) Bets Big On Growth. Is The Payoff Worth The Wait? — See source for full details.
Michael Burry Is Buying Lululemon (LULU) and MercadoLibre (MELI). Should You? — See source for full details.
After 30 consecutive quarters of more than 30% top-line growth, investors need more from the bottom line.
MercadoLibre outlines continued reinvestment as credit portfolio reaches $16.4B — See source for full details.
MercadoLibre Q2 2026 slides: $10B revenue milestone amid margin pressure — See source for full details.
Earnings Snapshot: MercadoLibre Q2 revenue surges 50% YOY; fintech MAUs hit 88M — See source for full details.
MercadoLibre earnings spotlight: Can revenue surge offset costs? — See source for full details.
Janus Henderson Investors, an investment management company, released its “Forty Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The Fund returned 19.00% in the second quarter of 2026, outperforming the Russell 1000 Growth Index’s 16.74% gain as strong stock selection and an overweight position in healthcare supported results. The […]
Loading $MELI research…